Bile Acid Binding Resins Improve Glucagon Receptor Agonist‐Mediated Weight Loss in Diet‐Induced Obese Mice
Together, these studies suggest that BARs enhance the antiobesity effect of GCGR agonism in DIO mice, representing a novel antiobesity strategy.
Authors
- Kirk M. Habegger (ORCID: https://orcid.org/0000-0002-0342-5480)
- Mackenzie Pearson (ORCID: https://orcid.org/0000-0002-8659-0659)
- William C. Roell (ORCID: https://orcid.org/0000-0002-2062-6217)
- Shelly Nason (ORCID: https://orcid.org/0000-0001-5285-6167)
- Teayoun Kim (ORCID: https://orcid.org/0000-0003-4664-6803)
- Richard D. DiMarchi (ORCID: https://orcid.org/0000-0003-0220-4085)
- Natalie Presedo
- Huixian Hong (ORCID: https://orcid.org/0000-0001-7283-8775)
- Jessica Antipenko (ORCID: https://orcid.org/0000-0001-5321-7316)
- K Seck
Institutions
- Eli Lilly (United States) (US)
- University of Alabama at Birmingham (US)
- Indiana University Bloomington (US)
Publication Details
- Journal
- Obesity
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1002/oby.70087
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Heart Association
- Eli Lilly and Company
- National Institutes of Health